Bellerophon Therapeutics Raises $60M In Market Debut
New Jersey-based, private equity-backed biotech Bellerophon Therapeutics LLC, which is developing therapies and medical devices for cardiopulmonary diseases, on Friday raised $60 million in an initial public offering, as biotechs continue...To view the full article, register now.
Already a subscriber? Click here to view full article